Reports for BAUSCH HEALTH, CANADA INC.

Company Name

BAUSCH HEALTH, CANADA INC.

Totals

Shortage reports

306
Actual shortage: 11 (4%)
Anticipated shortage: 7 (2%)
Avoided shortage: 25 (8%)
Resolved: 263 (86%)

Discontinuation Reports

1
To be discontinued: 0 (0%)
Discontinued: 1 (100%)
Reversed: 0 (0%)

Late reports

90 (29%)

Overdue reports

1 (6%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ETIBI 100MG TABLET Avoided shortage 2020-04-08 2020-05-07 111508
ETIBI 400MG TABLET Avoided shortage 2020-03-05 2020-03-05 107813
NORITATE 1% CREAM Avoided shortage 2018-10-19 2018-11-09 64990
ROFACT 300MG CAPSULE Avoided shortage 2018-05-11 2018-07-09 49062
ROFACT 300MG CAPSULE Avoided shortage 2023-03-13 2023-03-27 186883
ROFACT 150MG CAPSULE Avoided shortage 2020-04-09 2020-04-23 111785
ROFACT 150MG CAPSULE Avoided shortage 2023-04-28 2023-05-31 191061
CUPRIMINE 250MG CAPSULE Avoided shortage 2023-03-13 2023-03-23 186886
ARISTOCORT R 0.1% CREAM Avoided shortage 2022-04-07 2022-06-15 158242
AIROMIR 100MCG METERED-DOSE AEROSOL Avoided shortage 2020-04-23 2020-07-02 113070
ALDARA P 5 % Cream Avoided shortage 2017-03-13 2017-03-16 1637
ALDARA P 5% CREAM Avoided shortage 2018-06-20 2018-08-03 52705
ALDARA P 5% CREAM Avoided shortage 2019-03-22 2019-05-08 79306
ELIDEL 1% CREAM Avoided shortage 2019-07-24 2019-09-10 89893
BENZACLIN 5% 1% GEL Avoided shortage 2022-12-21 2023-03-23 179119
TIAZAC XC 240MG TABLET (EXTENDED-RELEASE) Avoided shortage 2019-09-10 2019-09-13 93532
RETIN-A MICRO 0.04% GEL Avoided shortage 2018-04-20 2018-05-11 46669
WELLBUTRIN XL 150MG TABLET (EXTENDED-RELEASE) Avoided shortage 2022-05-26 2022-08-31 161368
ZYCLARA 3.75% CREAM Avoided shortage 2019-07-24 2019-09-18 89896
LODALIS 625MG TABLET Avoided shortage 2020-10-21 2020-10-21 126828

Showing 21 to 40 of 306

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
THEOLAIR 80MG SOLUTION Discontinued 2021-04-26 2021-04-27 138081

Showing 1 to 1 of 1